This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2003 Jan 1;8(1):12-6.

doi: 10.1016/s1359-6446(02)02556-4.

Chris Lipinski discusses life and chemistry after the Rule of Five

Christopher A Lipinski¹

Affiliations

PMID: 12546981
DOI: 10.1016/s1359-6446(02)02556-4

Chris Lipinski discusses life and chemistry after the Rule of Five

Christopher A Lipinski. Drug Discov Today. 2003.

. 2003 Jan 1;8(1):12-6.

doi: 10.1016/s1359-6446(02)02556-4.

Author

Christopher A Lipinski¹

Affiliation

¹ Pfizer Global R&D, Groton Labs, Eastern Point Road, MS 8200-36, Groton, CT, USA.

PMID: 12546981
DOI: 10.1016/s1359-6446(02)02556-4

No abstract available

PubMed Disclaimer

Comment in

A 'rule of three' for fragment-based lead discovery?
Congreve M, Carr R, Murray C, Jhoti H. Congreve M, et al. Drug Discov Today. 2003 Oct 1;8(19):876-7. doi: 10.1016/s1359-6446(03)02831-9. Drug Discov Today. 2003. PMID: 14554012 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database